全文获取类型
收费全文 | 67325篇 |
免费 | 4957篇 |
国内免费 | 2436篇 |
专业分类
耳鼻咽喉 | 306篇 |
儿科学 | 921篇 |
妇产科学 | 1002篇 |
基础医学 | 11514篇 |
口腔科学 | 943篇 |
临床医学 | 3664篇 |
内科学 | 10474篇 |
皮肤病学 | 1043篇 |
神经病学 | 10355篇 |
特种医学 | 813篇 |
外国民族医学 | 19篇 |
外科学 | 4022篇 |
综合类 | 7362篇 |
现状与发展 | 7篇 |
预防医学 | 1545篇 |
眼科学 | 591篇 |
药学 | 12769篇 |
5篇 | |
中国医学 | 1408篇 |
肿瘤学 | 5955篇 |
出版年
2024年 | 45篇 |
2023年 | 755篇 |
2022年 | 1021篇 |
2021年 | 1891篇 |
2020年 | 1742篇 |
2019年 | 1779篇 |
2018年 | 1860篇 |
2017年 | 1883篇 |
2016年 | 1953篇 |
2015年 | 2289篇 |
2014年 | 3758篇 |
2013年 | 5004篇 |
2012年 | 3731篇 |
2011年 | 4340篇 |
2010年 | 3600篇 |
2009年 | 3696篇 |
2008年 | 3998篇 |
2007年 | 3610篇 |
2006年 | 3134篇 |
2005年 | 2696篇 |
2004年 | 2550篇 |
2003年 | 2346篇 |
2002年 | 1887篇 |
2001年 | 1628篇 |
2000年 | 1468篇 |
1999年 | 1254篇 |
1998年 | 1296篇 |
1997年 | 1240篇 |
1996年 | 1069篇 |
1995年 | 995篇 |
1994年 | 911篇 |
1993年 | 817篇 |
1992年 | 616篇 |
1991年 | 569篇 |
1990年 | 419篇 |
1989年 | 361篇 |
1988年 | 308篇 |
1987年 | 275篇 |
1986年 | 295篇 |
1985年 | 351篇 |
1984年 | 284篇 |
1983年 | 174篇 |
1982年 | 234篇 |
1981年 | 187篇 |
1980年 | 131篇 |
1979年 | 79篇 |
1978年 | 55篇 |
1977年 | 41篇 |
1976年 | 32篇 |
1975年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 25 毫秒
21.
22.
The splanchnic anti-inflammatory pathway, the efferent arm of the endogenous inflammatory reflex, has been shown to suppress the acute inflammatory response of rats to systemic lipopolysaccharide (LPS). Here we show for the first time that this applies also to mice, and that the reflex may be engaged by a range of inflammatory stimuli. Experiments were performed on mice under deep anaesthesia. Half the animals were subjected to bilateral section of the splanchnic sympathetic nerves, to disconnect the splanchnic anti-inflammatory pathway, while the remainder underwent a sham operation. Mice were then challenged intravenously with one of three inflammatory stimuli: the toll-like receptor (TLR)-4 agonist, LPS (60 µg/kg), the TLR-3 agonist Polyinosinic:polycytidylic acid (Poly I:C, 1 mg/kg) or the TLR-2 and -6 agonist dipalmitoyl-S-glyceryl cysteine (Pam2cys, 34 µg/kg). Ninety minutes later, blood was sampled by cardiac puncture for serum cytokine analysis. The splanchnic anti-inflammatory reflex action was assessed by comparing cytokine levels between animals with cut versus those with intact splanchnic nerves. A consistent pattern emerged: Tumor necrosis factor (TNF) levels in response to all three challenges were raised by prior splanchnic nerve section, while levels of the anti-inflammatory cytokine interleukin 10 (IL-10) were reduced. The raised TNF:IL-10 ratio after splanchnic nerve section indicates an enhanced inflammatory state when the reflex is disabled. These findings show for the first time that the inflammatory reflex drives a coordinated anti-inflammatory action also in mice, and demonstrate that its anti-inflammatory action is engaged, in similar fashion, by inflammatory stimuli mimicking a range of bacterial and viral infections. 相似文献
23.
24.
《Vaccine》2021,39(45):6601-6613
AKS-452 is a biologically-engineered vaccine comprising an Fc fusion protein of the SARS-CoV-2 viral spike protein receptor binding domain antigen (Ag) and human IgG1 Fc (SP/RBD-Fc) in clinical development for the induction and augmentation of neutralizing IgG titers against SARS-CoV-2 viral infection to address the COVID-19 pandemic. The Fc moiety is designed to enhance immunogenicity by increasing uptake via Fc-receptors (FcγR) on Ag-presenting cells (APCs) and prolonging exposure due to neonatal Fc receptor (FcRn) recycling. AKS-452 induced approximately 20-fold greater neutralizing IgG titers in mice relative to those induced by SP/RBD without the Fc moiety and induced comparable long-term neutralizing titers with a single dose vs. two doses. To further enhance immunogenicity, AKS-452 was evaluated in formulations containing a panel of adjuvants in which the water-in-oil adjuvant, Montanide™ ISA 720, enhanced neutralizing IgG titers by approximately 7-fold after one and two doses in mice, including the neutralization of live SARS-CoV-2 virus infection of VERO-E6 cells. Furthermore, ISA 720-adjuvanted AKS-452 was immunogenic in rabbits and non-human primates (NHPs) and protected from infection and clinical symptoms with live SARS-CoV-2 virus in NHPs (USA-WA1/2020 viral strain) and the K18 human ACE2-trangenic (K18-huACE2-Tg) mouse (South African B.1.351 viral variant). These preclinical studies support the initiation of Phase I clinical studies with adjuvanted AKS-452 with the expectation that this room-temperature stable, Fc-fusion subunit vaccine can be rapidly and inexpensively manufactured to provide billions of doses per year especially in regions where the cold-chain is difficult to maintain. 相似文献
25.
26.
Adam J. Rosenberg Yiu-Yin Cheung Fei Liu Todd E. Peterson James Silverman Ciaran M. Considine Daniel O. Claassen 《Journal of labelled compounds & radiopharmaceuticals》2022,65(8):223-229
(R)-[18F]MH.MZ ([18F]MH.MZ) is a promising positron emission tomography (PET) radiotracer for in vivo study of the 5-HT2A receptor. To facilitate clinical trials, a fully automated radiosynthesis procedure for [18F]MH.MZ was developed using commercially available materials on the iPhase Flexlab module. The overall synthesis time was 100 min with a radiochemical yield of 7 ± 0.9% (n = 3). The radiochemical purity was greater than 99% for [18F]MH.MZ with a molar activity of 361 ± 57 GBq/μmol (n = 3). The protocol described herein reliably provides [18F]MH.MZ that meets all relevant release criteria for a GMP radiopharmaceutical. 相似文献
27.
28.
《Saudi Pharmaceutical Journal》2022,30(5):595-604
Anthrax is a zoonotic infection caused by the gram-positive, aerobic, spore-forming bacterium Bacillus anthracis. Depending on the origin of the infection, serious health problems or mortality is possible. The virulence of B. anthracis is reliant on three pathogenic factors, which are secreted upon infection: protective antigen (PA), lethal factor (LF), and edema factor (EF). Systemic illness results from LF and EF entering cells through the formation of a complex with the heptameric form of PA, bound to the membrane of infected cells through its receptor. The currently available anthrax vaccines have multiple drawbacks, and recombinant PA is considered a promising second-generation vaccine candidate. However, the inherent chemical instability of PA through Asn deamidation at multiple sites prevents its use after long-term storage owing to loss of potency. Moreover, there is a distinct possibility of B. anthracis being used as a bioweapon; thus, the developed vaccine should remain efficacious and stable over the long-term. Second-generation anthrax vaccines with appropriate adjuvant formulations for enhanced immunogenicity and safety are desired. In this article, using protein engineering approaches, we have reviewed the stabilization of anthrax vaccine candidates that are currently licensed or under preclinical and clinical trials. We have also proposed a formulation to enhance recombinant PA vaccine potency via adjuvant formulation. 相似文献
29.
30.